Exploring Adverse Outcome Pathways for Nanomaterials with semantic web technologies Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.26434/chemrxiv-2023-kjcl6
Adverse Outcome Pathways (AOPs) have been proposed to facilitate mechanistic understanding of interactions of chemicals/materials with biological systems. Each AOP starts with a molecular initiating event (MIE) and possibly ends with adverse outcome(s) (AOs) via a series of key events (KEs). So far, the interaction of engineered nanomaterials (ENMs) with biomolecules, biomembranes, cells, and biological structures, in general, is not yet fully elucidated yet. There is also a huge lack of information on which AOPs are ENMs-relevant or -specific, despite numerous published data on toxicological endpoints they trigger, such as oxidative stress and inflammation. We propose to integrate related data and knowledge recently collected. Our approach combines the annotation of nanomaterials and their MIEs with ontology annotation to demonstrate how we can then query AOPs and biological pathway information for these materials. We conclude that a FAIR (Findable, Accessible, Interoperable, Reusable) representation of the ENM-MIE knowledge simplifies integration with other knowledge.
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.26434/chemrxiv-2023-kjcl6
- https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/649e8f65ba3e99daef490af1/original/exploring-adverse-outcome-pathways-for-nanomaterials-with-semantic-web-technologies.pdf
- OA Status
- gold
- References
- 68
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4382938079
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4382938079Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.26434/chemrxiv-2023-kjcl6Digital Object Identifier
- Title
-
Exploring Adverse Outcome Pathways for Nanomaterials with semantic web technologiesWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-07-03Full publication date if available
- Authors
-
Jeaphianne van Rijn, Marvin Martens, Ammar Ammar, Mihaela Roxana Cimpan, Valérie Fessard, Peter Hoet, Nina Jeliazkova, Sivakumar Murugadoss, Ivana Vinković Vrček, Egon WillighagenList of authors in order
- Landing page
-
https://doi.org/10.26434/chemrxiv-2023-kjcl6Publisher landing page
- PDF URL
-
https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/649e8f65ba3e99daef490af1/original/exploring-adverse-outcome-pathways-for-nanomaterials-with-semantic-web-technologies.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/649e8f65ba3e99daef490af1/original/exploring-adverse-outcome-pathways-for-nanomaterials-with-semantic-web-technologies.pdfDirect OA link when available
- Concepts
-
Adverse Outcome Pathway, Ontology, Computer science, Interoperability, Semantic Web, Representation (politics), Data science, Computational biology, Information retrieval, World Wide Web, Biology, Politics, Epistemology, Philosophy, Political science, LawTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
68Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4382938079 |
|---|---|
| doi | https://doi.org/10.26434/chemrxiv-2023-kjcl6 |
| ids.doi | https://doi.org/10.26434/chemrxiv-2023-kjcl6 |
| ids.openalex | https://openalex.org/W4382938079 |
| fwci | 0.0 |
| type | preprint |
| title | Exploring Adverse Outcome Pathways for Nanomaterials with semantic web technologies |
| awards[0].id | https://openalex.org/G4967985424 |
| awards[0].funder_id | https://openalex.org/F4320332999 |
| awards[0].display_name | |
| awards[0].funder_award_id | 862195 |
| awards[0].funder_display_name | Horizon 2020 Framework Programme |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10211 |
| topics[0].field.id | https://openalex.org/fields/17 |
| topics[0].field.display_name | Computer Science |
| topics[0].score | 0.9858999848365784 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1703 |
| topics[0].subfield.display_name | Computational Theory and Mathematics |
| topics[0].display_name | Computational Drug Discovery Methods |
| topics[1].id | https://openalex.org/T14293 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9218999743461609 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2739 |
| topics[1].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[1].display_name | Biotechnology and Related Fields |
| funders[0].id | https://openalex.org/F4320332999 |
| funders[0].ror | https://ror.org/00k4n6c32 |
| funders[0].display_name | Horizon 2020 Framework Programme |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2910206359 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8214951753616333 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q18559532 |
| concepts[0].display_name | Adverse Outcome Pathway |
| concepts[1].id | https://openalex.org/C25810664 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6677979230880737 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q44325 |
| concepts[1].display_name | Ontology |
| concepts[2].id | https://openalex.org/C41008148 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6385848522186279 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[2].display_name | Computer science |
| concepts[3].id | https://openalex.org/C20136886 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6147639751434326 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q749647 |
| concepts[3].display_name | Interoperability |
| concepts[4].id | https://openalex.org/C2129575 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4748385548591614 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q54837 |
| concepts[4].display_name | Semantic Web |
| concepts[5].id | https://openalex.org/C2776359362 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4337884485721588 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2145286 |
| concepts[5].display_name | Representation (politics) |
| concepts[6].id | https://openalex.org/C2522767166 |
| concepts[6].level | 1 |
| concepts[6].score | 0.41947075724601746 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2374463 |
| concepts[6].display_name | Data science |
| concepts[7].id | https://openalex.org/C70721500 |
| concepts[7].level | 1 |
| concepts[7].score | 0.29447823762893677 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[7].display_name | Computational biology |
| concepts[8].id | https://openalex.org/C23123220 |
| concepts[8].level | 1 |
| concepts[8].score | 0.21366673707962036 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q816826 |
| concepts[8].display_name | Information retrieval |
| concepts[9].id | https://openalex.org/C136764020 |
| concepts[9].level | 1 |
| concepts[9].score | 0.18030545115470886 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q466 |
| concepts[9].display_name | World Wide Web |
| concepts[10].id | https://openalex.org/C86803240 |
| concepts[10].level | 0 |
| concepts[10].score | 0.13953933119773865 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[10].display_name | Biology |
| concepts[11].id | https://openalex.org/C94625758 |
| concepts[11].level | 2 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7163 |
| concepts[11].display_name | Politics |
| concepts[12].id | https://openalex.org/C111472728 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q9471 |
| concepts[12].display_name | Epistemology |
| concepts[13].id | https://openalex.org/C138885662 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[13].display_name | Philosophy |
| concepts[14].id | https://openalex.org/C17744445 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[14].display_name | Political science |
| concepts[15].id | https://openalex.org/C199539241 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[15].display_name | Law |
| keywords[0].id | https://openalex.org/keywords/adverse-outcome-pathway |
| keywords[0].score | 0.8214951753616333 |
| keywords[0].display_name | Adverse Outcome Pathway |
| keywords[1].id | https://openalex.org/keywords/ontology |
| keywords[1].score | 0.6677979230880737 |
| keywords[1].display_name | Ontology |
| keywords[2].id | https://openalex.org/keywords/computer-science |
| keywords[2].score | 0.6385848522186279 |
| keywords[2].display_name | Computer science |
| keywords[3].id | https://openalex.org/keywords/interoperability |
| keywords[3].score | 0.6147639751434326 |
| keywords[3].display_name | Interoperability |
| keywords[4].id | https://openalex.org/keywords/semantic-web |
| keywords[4].score | 0.4748385548591614 |
| keywords[4].display_name | Semantic Web |
| keywords[5].id | https://openalex.org/keywords/representation |
| keywords[5].score | 0.4337884485721588 |
| keywords[5].display_name | Representation (politics) |
| keywords[6].id | https://openalex.org/keywords/data-science |
| keywords[6].score | 0.41947075724601746 |
| keywords[6].display_name | Data science |
| keywords[7].id | https://openalex.org/keywords/computational-biology |
| keywords[7].score | 0.29447823762893677 |
| keywords[7].display_name | Computational biology |
| keywords[8].id | https://openalex.org/keywords/information-retrieval |
| keywords[8].score | 0.21366673707962036 |
| keywords[8].display_name | Information retrieval |
| keywords[9].id | https://openalex.org/keywords/world-wide-web |
| keywords[9].score | 0.18030545115470886 |
| keywords[9].display_name | World Wide Web |
| keywords[10].id | https://openalex.org/keywords/biology |
| keywords[10].score | 0.13953933119773865 |
| keywords[10].display_name | Biology |
| language | en |
| locations[0].id | doi:10.26434/chemrxiv-2023-kjcl6 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/649e8f65ba3e99daef490af1/original/exploring-adverse-outcome-pathways-for-nanomaterials-with-semantic-web-technologies.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.26434/chemrxiv-2023-kjcl6 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5042912049 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5026-7705 |
| authorships[0].author.display_name | Jeaphianne van Rijn |
| authorships[0].countries | NL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I34352273 |
| authorships[0].affiliations[0].raw_affiliation_string | Maastricht University |
| authorships[0].institutions[0].id | https://openalex.org/I34352273 |
| authorships[0].institutions[0].ror | https://ror.org/02jz4aj89 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I34352273 |
| authorships[0].institutions[0].country_code | NL |
| authorships[0].institutions[0].display_name | Maastricht University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jeaphianne van Rijn |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Maastricht University |
| authorships[1].author.id | https://openalex.org/A5046933371 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2230-0840 |
| authorships[1].author.display_name | Marvin Martens |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I34352273 |
| authorships[1].affiliations[0].raw_affiliation_string | Maastricht University |
| authorships[1].institutions[0].id | https://openalex.org/I34352273 |
| authorships[1].institutions[0].ror | https://ror.org/02jz4aj89 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I34352273 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | Maastricht University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Marvin Martens |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Maastricht University |
| authorships[2].author.id | https://openalex.org/A5066436740 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8399-8990 |
| authorships[2].author.display_name | Ammar Ammar |
| authorships[2].countries | NL |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I34352273 |
| authorships[2].affiliations[0].raw_affiliation_string | Maastricht University |
| authorships[2].institutions[0].id | https://openalex.org/I34352273 |
| authorships[2].institutions[0].ror | https://ror.org/02jz4aj89 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I34352273 |
| authorships[2].institutions[0].country_code | NL |
| authorships[2].institutions[0].display_name | Maastricht University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ammar Ammar |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Maastricht University |
| authorships[3].author.id | https://openalex.org/A5066367847 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-2029-3173 |
| authorships[3].author.display_name | Mihaela Roxana Cimpan |
| authorships[3].countries | NO |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4432739 |
| authorships[3].affiliations[0].raw_affiliation_string | University of Bergen |
| authorships[3].institutions[0].id | https://openalex.org/I4432739 |
| authorships[3].institutions[0].ror | https://ror.org/03zga2b32 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I4432739 |
| authorships[3].institutions[0].country_code | NO |
| authorships[3].institutions[0].display_name | University of Bergen |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Mihaela-Roxana Cimpan |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | University of Bergen |
| authorships[4].author.id | https://openalex.org/A5064665895 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9046-9117 |
| authorships[4].author.display_name | Valérie Fessard |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210138120 |
| authorships[4].affiliations[0].raw_affiliation_string | French Agency for Food, Environmental and Occupational Health & Safety |
| authorships[4].institutions[0].id | https://openalex.org/I4210138120 |
| authorships[4].institutions[0].ror | https://ror.org/0471kz689 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210138120, https://openalex.org/I4413696090 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Valerie Fessard |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | French Agency for Food, Environmental and Occupational Health & Safety |
| authorships[5].author.id | https://openalex.org/A5061521668 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0292-6603 |
| authorships[5].author.display_name | Peter Hoet |
| authorships[5].countries | BE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I99464096 |
| authorships[5].affiliations[0].raw_affiliation_string | KU Leuven |
| authorships[5].institutions[0].id | https://openalex.org/I99464096 |
| authorships[5].institutions[0].ror | https://ror.org/05f950310 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I99464096 |
| authorships[5].institutions[0].country_code | BE |
| authorships[5].institutions[0].display_name | KU Leuven |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Peter Hoet |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | KU Leuven |
| authorships[6].author.id | https://openalex.org/A5056989071 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-4322-6179 |
| authorships[6].author.display_name | Nina Jeliazkova |
| authorships[6].countries | BG |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210145716 |
| authorships[6].affiliations[0].raw_affiliation_string | IDEAconsult |
| authorships[6].institutions[0].id | https://openalex.org/I4210145716 |
| authorships[6].institutions[0].ror | https://ror.org/043r2f182 |
| authorships[6].institutions[0].type | other |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210145716 |
| authorships[6].institutions[0].country_code | BG |
| authorships[6].institutions[0].display_name | IDEAconsult |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Nina Jeliazkova |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | IDEAconsult |
| authorships[7].author.id | https://openalex.org/A5032708932 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8414-0569 |
| authorships[7].author.display_name | Sivakumar Murugadoss |
| authorships[7].countries | BE |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210145009 |
| authorships[7].affiliations[0].raw_affiliation_string | Sciensano (Belgium) |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I99464096 |
| authorships[7].affiliations[1].raw_affiliation_string | KU Leuven |
| authorships[7].institutions[0].id | https://openalex.org/I99464096 |
| authorships[7].institutions[0].ror | https://ror.org/05f950310 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I99464096 |
| authorships[7].institutions[0].country_code | BE |
| authorships[7].institutions[0].display_name | KU Leuven |
| authorships[7].institutions[1].id | https://openalex.org/I4210145009 |
| authorships[7].institutions[1].ror | https://ror.org/04ejags36 |
| authorships[7].institutions[1].type | company |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210145009 |
| authorships[7].institutions[1].country_code | BE |
| authorships[7].institutions[1].display_name | Sciensano (Belgium) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Sivakumar Murugadoss |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | KU Leuven, Sciensano (Belgium) |
| authorships[8].author.id | https://openalex.org/A5010261267 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-1382-5581 |
| authorships[8].author.display_name | Ivana Vinković Vrček |
| authorships[8].countries | HR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210147716 |
| authorships[8].affiliations[0].raw_affiliation_string | Institute for Medical Research and Occupational Health |
| authorships[8].institutions[0].id | https://openalex.org/I4210147716 |
| authorships[8].institutions[0].ror | https://ror.org/052zr0n46 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I1301669915, https://openalex.org/I4210147716 |
| authorships[8].institutions[0].country_code | HR |
| authorships[8].institutions[0].display_name | Institute for Medical Research and Occupational Health |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ivana Vinković Vrček |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Institute for Medical Research and Occupational Health |
| authorships[9].author.id | https://openalex.org/A5060194743 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Egon Willighagen |
| authorships[9].affiliations[0].raw_affiliation_string | maastricht uni |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Egon Willighagen |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | maastricht uni |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/649e8f65ba3e99daef490af1/original/exploring-adverse-outcome-pathways-for-nanomaterials-with-semantic-web-technologies.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Exploring Adverse Outcome Pathways for Nanomaterials with semantic web technologies |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10211 |
| primary_topic.field.id | https://openalex.org/fields/17 |
| primary_topic.field.display_name | Computer Science |
| primary_topic.score | 0.9858999848365784 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1703 |
| primary_topic.subfield.display_name | Computational Theory and Mathematics |
| primary_topic.display_name | Computational Drug Discovery Methods |
| related_works | https://openalex.org/W2782801093, https://openalex.org/W2038304359, https://openalex.org/W2725822996, https://openalex.org/W4381855166, https://openalex.org/W2947536642, https://openalex.org/W2093262417, https://openalex.org/W2915376283, https://openalex.org/W2123131699, https://openalex.org/W3088834846, https://openalex.org/W913131694 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.26434/chemrxiv-2023-kjcl6 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/649e8f65ba3e99daef490af1/original/exploring-adverse-outcome-pathways-for-nanomaterials-with-semantic-web-technologies.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.26434/chemrxiv-2023-kjcl6 |
| primary_location.id | doi:10.26434/chemrxiv-2023-kjcl6 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/649e8f65ba3e99daef490af1/original/exploring-adverse-outcome-pathways-for-nanomaterials-with-semantic-web-technologies.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.26434/chemrxiv-2023-kjcl6 |
| publication_date | 2023-07-03 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2779798720, https://openalex.org/W4221072094, https://openalex.org/W4318592280, https://openalex.org/W3011076157, https://openalex.org/W1873323908, https://openalex.org/W2037739053, https://openalex.org/W2495089965, https://openalex.org/W2000089305, https://openalex.org/W1990878286, https://openalex.org/W2302501749, https://openalex.org/W6795242278, https://openalex.org/W6785918294, https://openalex.org/W2982975240, https://openalex.org/W4255123389, https://openalex.org/W3163430988, https://openalex.org/W3190330365, https://openalex.org/W2033377040, https://openalex.org/W2049774671, https://openalex.org/W3198537437, https://openalex.org/W2946734970, https://openalex.org/W2016976521, https://openalex.org/W2147018385, https://openalex.org/W2087779040, https://openalex.org/W2113142309, https://openalex.org/W2144427809, https://openalex.org/W2975135115, https://openalex.org/W2034761114, https://openalex.org/W2771881282, https://openalex.org/W3179249808, https://openalex.org/W4200358749, https://openalex.org/W2969875029, https://openalex.org/W1544395527, https://openalex.org/W1999801985, https://openalex.org/W2802114091, https://openalex.org/W2413065346, https://openalex.org/W2066102814, https://openalex.org/W3188172155, https://openalex.org/W2271636378, https://openalex.org/W1980389512, https://openalex.org/W3163425692, https://openalex.org/W2074906023, https://openalex.org/W2886942038, https://openalex.org/W4210530503, https://openalex.org/W1983327991, https://openalex.org/W2110279208, https://openalex.org/W4240911442, https://openalex.org/W812314648, https://openalex.org/W2941029570, https://openalex.org/W2283018371, https://openalex.org/W3126350870, https://openalex.org/W2295890767, https://openalex.org/W2156895262, https://openalex.org/W2098174226, https://openalex.org/W4318592281, https://openalex.org/W4235097502, https://openalex.org/W4248593017, https://openalex.org/W2772061256, https://openalex.org/W3102147110, https://openalex.org/W4293105686, https://openalex.org/W2061662801, https://openalex.org/W2060835497, https://openalex.org/W2145857667, https://openalex.org/W2150829627, https://openalex.org/W1577783107, https://openalex.org/W2335636709, https://openalex.org/W2767500773, https://openalex.org/W3005793252, https://openalex.org/W3109746568 |
| referenced_works_count | 68 |
| abstract_inverted_index.a | 22, 35, 67, 135 |
| abstract_inverted_index.So | 41 |
| abstract_inverted_index.We | 94, 132 |
| abstract_inverted_index.as | 89 |
| abstract_inverted_index.in | 56 |
| abstract_inverted_index.is | 58, 65 |
| abstract_inverted_index.of | 11, 13, 37, 45, 70, 109, 142 |
| abstract_inverted_index.on | 72, 83 |
| abstract_inverted_index.or | 77 |
| abstract_inverted_index.to | 7, 96, 117 |
| abstract_inverted_index.we | 120 |
| abstract_inverted_index.AOP | 19 |
| abstract_inverted_index.Our | 104 |
| abstract_inverted_index.and | 27, 53, 92, 100, 111, 125 |
| abstract_inverted_index.are | 75 |
| abstract_inverted_index.can | 121 |
| abstract_inverted_index.for | 129 |
| abstract_inverted_index.how | 119 |
| abstract_inverted_index.key | 38 |
| abstract_inverted_index.not | 59 |
| abstract_inverted_index.the | 43, 107, 143 |
| abstract_inverted_index.via | 34 |
| abstract_inverted_index.yet | 60 |
| abstract_inverted_index.AOPs | 74, 124 |
| abstract_inverted_index.Each | 18 |
| abstract_inverted_index.FAIR | 136 |
| abstract_inverted_index.MIEs | 113 |
| abstract_inverted_index.also | 66 |
| abstract_inverted_index.been | 5 |
| abstract_inverted_index.data | 82, 99 |
| abstract_inverted_index.ends | 29 |
| abstract_inverted_index.far, | 42 |
| abstract_inverted_index.have | 4 |
| abstract_inverted_index.huge | 68 |
| abstract_inverted_index.lack | 69 |
| abstract_inverted_index.such | 88 |
| abstract_inverted_index.that | 134 |
| abstract_inverted_index.then | 122 |
| abstract_inverted_index.they | 86 |
| abstract_inverted_index.with | 15, 21, 30, 49, 114, 148 |
| abstract_inverted_index.yet. | 63 |
| abstract_inverted_index.(AOs) | 33 |
| abstract_inverted_index.(MIE) | 26 |
| abstract_inverted_index.There | 64 |
| abstract_inverted_index.event | 25 |
| abstract_inverted_index.fully | 61 |
| abstract_inverted_index.other | 149 |
| abstract_inverted_index.query | 123 |
| abstract_inverted_index.their | 112 |
| abstract_inverted_index.these | 130 |
| abstract_inverted_index.which | 73 |
| abstract_inverted_index.(AOPs) | 3 |
| abstract_inverted_index.(ENMs) | 48 |
| abstract_inverted_index.(KEs). | 40 |
| abstract_inverted_index.cells, | 52 |
| abstract_inverted_index.events | 39 |
| abstract_inverted_index.series | 36 |
| abstract_inverted_index.starts | 20 |
| abstract_inverted_index.stress | 91 |
| abstract_inverted_index.Adverse | 0 |
| abstract_inverted_index.ENM-MIE | 144 |
| abstract_inverted_index.Outcome | 1 |
| abstract_inverted_index.adverse | 31 |
| abstract_inverted_index.despite | 79 |
| abstract_inverted_index.pathway | 127 |
| abstract_inverted_index.propose | 95 |
| abstract_inverted_index.related | 98 |
| abstract_inverted_index.Pathways | 2 |
| abstract_inverted_index.approach | 105 |
| abstract_inverted_index.combines | 106 |
| abstract_inverted_index.conclude | 133 |
| abstract_inverted_index.general, | 57 |
| abstract_inverted_index.numerous | 80 |
| abstract_inverted_index.ontology | 115 |
| abstract_inverted_index.possibly | 28 |
| abstract_inverted_index.proposed | 6 |
| abstract_inverted_index.recently | 102 |
| abstract_inverted_index.systems. | 17 |
| abstract_inverted_index.trigger, | 87 |
| abstract_inverted_index.Reusable) | 140 |
| abstract_inverted_index.endpoints | 85 |
| abstract_inverted_index.integrate | 97 |
| abstract_inverted_index.knowledge | 101, 145 |
| abstract_inverted_index.molecular | 23 |
| abstract_inverted_index.oxidative | 90 |
| abstract_inverted_index.published | 81 |
| abstract_inverted_index.(Findable, | 137 |
| abstract_inverted_index.-specific, | 78 |
| abstract_inverted_index.annotation | 108, 116 |
| abstract_inverted_index.biological | 16, 54, 126 |
| abstract_inverted_index.collected. | 103 |
| abstract_inverted_index.elucidated | 62 |
| abstract_inverted_index.engineered | 46 |
| abstract_inverted_index.facilitate | 8 |
| abstract_inverted_index.initiating | 24 |
| abstract_inverted_index.knowledge. | 150 |
| abstract_inverted_index.materials. | 131 |
| abstract_inverted_index.outcome(s) | 32 |
| abstract_inverted_index.simplifies | 146 |
| abstract_inverted_index.Accessible, | 138 |
| abstract_inverted_index.demonstrate | 118 |
| abstract_inverted_index.information | 71, 128 |
| abstract_inverted_index.integration | 147 |
| abstract_inverted_index.interaction | 44 |
| abstract_inverted_index.mechanistic | 9 |
| abstract_inverted_index.structures, | 55 |
| abstract_inverted_index.interactions | 12 |
| abstract_inverted_index.ENMs-relevant | 76 |
| abstract_inverted_index.biomembranes, | 51 |
| abstract_inverted_index.biomolecules, | 50 |
| abstract_inverted_index.inflammation. | 93 |
| abstract_inverted_index.nanomaterials | 47, 110 |
| abstract_inverted_index.toxicological | 84 |
| abstract_inverted_index.understanding | 10 |
| abstract_inverted_index.Interoperable, | 139 |
| abstract_inverted_index.representation | 141 |
| abstract_inverted_index.chemicals/materials | 14 |
| cited_by_percentile_year | |
| countries_distinct_count | 6 |
| institutions_distinct_count | 10 |
| citation_normalized_percentile.value | 0.15727869 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |